Publications
5674 Results
- Journal / Conference
- JAMA Network Open Oct 3;5(10):e2238191
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID36279134
- PMC
- PMC9593234
- Study Number(s)
- S1415CD
Effects of a guideline-informed clinical decision support system intervention to improve colony stimulating factor prescribing: A Pragmatic Cluster-Randomized Trial
- Journal / Conference
- Statistics in Medicine 2022 Oct 30;41(24):4756-4780. doi: 10.1002/sim.9447. Epub 2022 Jul 5
- Year
- 2022
- Research Committee(s)
- Prevention, Screening, and Surveillance, Prevention, Screening, and and Surveillance
- PMID
- PMID36224712
- Study Number(s)
- S0000
Accommodating population differences when validating risk prediction models
- Journal / Conference
- JAMA Network Open 2022 Oct 3;5(10):e2234445
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery and Multiple sites
- PMID
- PMID36215073
- PMC
- PMC9552895
Trends in Obesity Prevalence Among Patients Enrolled in Clinical Trials for Obesity-Related Cancers, 1986 to 2016
- Journal / Conference
- Journal of Comparative Effectiveness Research Dec;11(18):1313-1321
- Year
- 2022
- Research Committee(s)
- Cancer Care Delivery
- PMID
- PMID36378570
- PMC
- PMC9832319
- Study Number(s)
- S1415CD
An Evaluation of Stakeholder Engagement in Comparative Effectiveness Research: Lessons Learned from SWOG S1415CD
- Journal / Conference
- Cancer Epidemiology Biomarkers & Prevention Nov 2;31(11):2063-2069
- Year
- 2022
- Research Committee(s)
- Prevention, Screening, and and Surveillance
- PMID
- PMID36084322
- PMC
- PMC9756313
- Study Number(s)
- S0000
Differential Biopsy Patterns Influence Associations Between Multivitamin Use and Prostate Cancer Risk in the Selenium and Vitamin E Cancer Prevention Trial
- Journal / Conference
- Journal of Clinical Oncology Oct 26;JCO2102371. doi: 10.1200/JCO.21.02371. Online ahead of print.
- Year
- 2022
- Research Committee(s)
- Early Therapeutics and Rare Cancers
- PMID
- PMID36288512
- Study Number(s)
- CTSU/A071401
Alliance A071401: Phase II trial of FAK inhibition in meningiomas with somatic NF2 mutations
- Journal / Conference
- JAMA Oncology Sep 1;8(9):1263-1270. doi: 10.1001/jamaoncol.2022.2319
- Year
- 2022
- Research Committee(s)
- Gastrointestinal
- PMID
- PMID35834226
- PMC
- PMC9284408
- Study Number(s)
- CTSU/A021501
Efficacy of Preoperative mFOLFIRINOX vs mFOLFIRINOX Plus Hypofractionated Radiotherapy for Borderline Resectable Adenocarcinoma of the Pancreas: The A021501 Phase 2 Randomized Clinical Trial
- Journal / Conference
- Society for Clinical Trials (MAY 15-18, 2022 San Diego, CA), oral
- Year
- 2022
- Research Committee(s)
- Breast
- Study Number(s)
- S0500
The application of ACCEPT software in retrospective analysis of specimen data (SWOG S0500 Translational Medicine Project)
- Journal / Conference
- Journal of Clinical Oncology Dec 20;40(36):4240-4249
- Year
- 2022
- PMID
- PMID35867947
- PMC
- PMC9916043
A Phase II Study of Enzalutamide for Patients with Androgen Receptor Positive Salivary Gland Cancers (Alliance A091404)
- Journal / Conference
- American Statistical Society Meeting, oral
- Year
- 2022
- Research Committee(s)
- Multiple sites